
Wed 22 October 2025
Warszawa (PL)
10/5°C
Tue
|
Wed
|
Thu
|
Fri
|
Sat
|
11 |
15 |
16 |
13 |
9 |
Wed 22 October 2025
Praha (CZ)
10/9°C
Tue
|
Wed
|
Thu
|
Fri
|
Sat
|
17 |
17 |
19 |
13 |
11 |
Wed 22 October 2025
Bratislava (SK)
14/5°C
Tue
|
Wed
|
Thu
|
Fri
|
Sat
|
10 |
17 |
16 |
13 |
11 |
Wed 22 October 2025
Budapest (HU)
13/8°C
Tue
|
Wed
|
Thu
|
Fri
|
Sat
|
13 |
15 |
20 |
12 |
14 |



February 8th, 2021
The Health Ministry will recommend the use of the drugs for COVID-19 based on monoclonal antibodies, namely kasirivimab and imdevimab from the Regeneron firm and bamlanivimab from the Eli Lilly firm, it said in a press release today. These drugs are suitable for people with a high risk of severe symptoms of the infection disease, for example patients after transplants. The target groups are yet to be defined.
CTK
Pageviews this month:
167,860